Picture of Veradigm logo

MDRX Veradigm News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid Cap

Allscripts Healthcare Solutions Inc expected to post earnings of 17 cents a share - Earnings Preview

* Allscripts Healthcare Solutions Inc  MDRX.OQ   MDRX.O  is
expected to show a fall in quarterly revenue when it reports
results on August 5. 
* The Chicago, Illinois-based company is expected to report   a
8.1% decrease in revenue to $373.454 million from $406.2 million
a year ago, according to the mean estimate from 13 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Allscripts Healthcare
Solutions Inc is for earnings of 17 cents per share. For the
same quarter last year, the company reported earnings of 18
cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 6 "strong buy" or "buy," 11
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Allscripts
Healthcare Solutions Inc is $17​, about 1% below​ its last
closing price of $17.17. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  0.15        0.15       0.19      Beat    23.5
 Dec. 31 2020  0.22        0.21       0.29      Beat    36.6
 Sep. 30 2020  0.19        0.19       0.20      Beat    5.6​
 Jun. 30 2020  0.12        0.12       0.18      Beat    49.3
 Mar.          0.14​       0.15       0.09      Missed  -39.4​
 31​ 2020​                                              
 Dec. 31 2019  0.18        0.18       0.17      Missed  -7​
 Sep. 30 2019  0.17        0.17       0.17      Met     1.8
 Jun. 30 2019  0.16        0.16       0.17      Beat    5.1
 This summary was machine generated August 3 at 21:10 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Veradigm

See all news